$GRAM
Gold Flora Corp. Stock $gram

$gram Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000187694524000044 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$31.64M	$32.15M	$18.05M
YoY Change	63.01%	78.09%	-45.67%
Cost Of Revenue	$24.39M	$22.12M	$10.27M
YoY Change	144.54%	115.36%	-58.98%
Gross Profit	$7.248M	$10.03M	$7.781M
YoY Change	-23.18%	28.89%	-4.93%
Gross Profit Margin	22.91%	31.19%	43.1%
Selling, General & Admin	$20.77M	$18.97M	$9.325M
YoY Change	22.56%	103.38%	-72.69%
% of Gross Profit	286.51%	189.11%	119.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.049M	$4.050M	$2.725M
YoY Change	49.29%	48.63%	-57.91%
% of Gross Profit	55.86%	40.38%	35.02%
Operating Expenses	$20.77M	$18.97M	$22.10M
YoY Change	-30.52%	-14.19%	-45.58%
Operating Profit	-$13.52M	-$8.937M	-$14.32M
YoY Change	-35.19%	-37.59%	-55.84%
Interest Expense	$4.714M	$4.328M	$1.264M
YoY Change	289.93%	242.42%	-256.67%
% of Operating Profit
Other Income/Expense, Net	-$9.700M	-$3.780M	-$900.4K
YoY Change	1079.98%	319.81%	-263.53%
Pretax Income			-$15.80M
YoY Change			-52.05%
Income Tax	$736.0K	$987.0K	$714.4K
% Of Pretax Income
Net Earnings	-$23.84M	-$13.64M	-$16.51M
YoY Change	-1.96%	-17.41%	-51.0%
Net Earnings / Revenue	-75.33%	-42.41%	-91.45%
Basic Earnings Per Share	-$0.08	-$0.05	-$0.10
Diluted Earnings Per Share	-$0.08	-$0.05	-$0.16
COMMON SHARES
Basic Shares Outstanding	287.6M shares	287.5M shares	118.8M shares
Diluted Shares Outstanding	287.6M shares	287.5M shares	94.35M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$76.11M
YoY Change			-50.0%
Cash & Equivalents	$10.68M	$14.22M	$76.11M
Short-Term Investments
Other Short-Term Assets	$253.0K	$2.756M	$6.044M
YoY Change	-95.81%	-54.4%	-48.53%
Inventory	$18.35M	$20.05M	$6.986M
Prepaid Expenses			$10.03M
Receivables	$2.204M	$2.845M	$928.6K
Other Receivables			$123.2K
Total Short-Term Assets	$43.47M	$51.41M	$99.88M
YoY Change	-46.71%	-48.53%	-49.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.28M	$37.88M	$14.86M
YoY Change	166.39%	154.97%	-78.92%
Goodwill
YoY Change
Intangibles	$43.85M	$44.99M	$97.56M
YoY Change	-54.2%	-53.89%
Long-Term Investments			$1.478M
YoY Change			-50.19%
Other Assets			$1.900M
YoY Change			-7.5%
Total Long-Term Assets	$164.9M	$169.2M	$158.9M
YoY Change	5.53%	6.47%	-52.75%
TOTAL ASSETS
Total Short-Term Assets	$43.47M	$51.41M	$99.88M
Total Long-Term Assets	$164.9M	$169.2M	$158.9M
Total Assets	$208.4M	$220.6M	$258.8M
YoY Change	-12.38%	-14.76%	-51.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.84M	$15.49M	$5.621M
YoY Change	203.19%	175.56%	-9.23%
Accrued Expenses			$18.74M
YoY Change			51.57%
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due			$156.2K
YoY Change			239.89%
Total Short-Term Liabilities	$93.29M	$97.15M	$33.54M
YoY Change	145.77%	189.64%	-34.48%
LONG-TERM LIABILITIES
Long-Term Debt			$36.57M
YoY Change			-0.43%
Other Long-Term Liabilities			$22.35M
YoY Change			-25.77%
Total Long-Term Liabilities			$58.92M
YoY Change			-11.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$93.29M	$97.15M	$33.54M
Total Long-Term Liabilities			$58.92M
Total Liabilities	$253.0M	$241.4M	$112.6M
YoY Change	118.95%	114.31%	-44.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$148.3M	-$124.5M	-$852.2M
YoY Change	-83.08%	-85.39%
Common Stock	$2.876M	$2.875M	$998.3M
YoY Change	-99.71%	-99.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$44.57M	-$20.83M	$146.2M
YoY Change
Total Liabilities & Shareholders Equity	$208.4M	$220.6M	$258.8M
YoY Change	-12.38%	-14.76%	-51.53%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$23.84M	-$13.64M	-$16.51M
YoY Change	-1.96%	-17.41%	-51.0%
Depreciation, Depletion And Amortization	$4.049M	$4.050M	$2.725M
YoY Change	49.29%	48.63%	-57.91%
Cash From Operating Activities		-$4.359M	-$13.64M
YoY Change		-68.04%	-47.22%
INVESTING ACTIVITIES
Capital Expenditures		$651.0K	$244.8K
YoY Change		165.94%	-121.76%
Acquisitions
YoY Change
Other Investing Activities			-$2.171M
YoY Change			-138.64%
Cash From Investing Activities		-$680.0K	-$2.416M
YoY Change		-71.85%	-153.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$3.278M	-$1.531M
YoY Change		114.11%	16.54%
NET CHANGE
Cash From Operating Activities		-$4.359M	-$13.64M
Cash From Investing Activities		-$680.0K	-$2.416M
Cash From Financing Activities		-$3.278M	-$1.531M
Net Change In Cash		-$8.317M	-$17.59M
YoY Change		-52.71%	-22.39%
FREE CASH FLOW
Cash From Operating Activities		-$4.359M	-$13.64M
Capital Expenditures		$651.0K	$244.8K
Free Cash Flow		-$5.010M	-$13.88M
YoY Change		-63.92%	-43.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Liabilities Liabilities	241375000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	233614000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4670000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5150000	usd
CY2024Q1	gram	Security Deposit Liability And Other Long Term Liabilities Non Current SecurityDepositLiabilityAndOtherLongTermLiabilitiesNonCurrent	64000	usd
CY2023Q4	gram	Security Deposit Liability And Other Long Term Liabilities Non Current SecurityDepositLiabilityAndOtherLongTermLiabilitiesNonCurrent	64000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	287527727	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	287527727	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2875000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2874000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100769000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	100577000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124474000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110833000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-20830000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7382000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	65000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	134000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20765000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7248000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	220610000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	226366000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32153000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15652000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	22124000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	11606000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	10029000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4046000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18966000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8933000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	18966000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	8933000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8937000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4887000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	772000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1599000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3379000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2574000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	177000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	532000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	548000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1016000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3780000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3689000	usd
CY2024Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12717000	usd
CY2023Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-8576000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	987000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	765000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-13704000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9341000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-69000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-19000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-13635000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9322000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	395000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13635000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9717000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	287515421	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	287515421	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94346683	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94346683	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-23579000	usd
CY2023Q1	gram	Adjustments To Additional Paid In Capital Contributions From Reverse Recapitalization Transaction AdjustmentsToAdditionalPaidInCapitalContributionsFromReverseRecapitalizationTransaction	97000	usd
CY2023Q1	gram	Stock Repurchased And Retired During Period Value Participation Units StockRepurchasedAndRetiredDuringPeriodValueParticipationUnits	0	usd
CY2023Q1	gram	Accrued Preferred Distribution To Members AccruedPreferredDistributionToMembers	395000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9341000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33162000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7248000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	193000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-13704000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20765000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-13704000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9341000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4050000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2117000	usd
CY2024Q1	gram	Non Cash Portion Of Operating Lease Expense NonCashPortionOfOperatingLeaseExpense	-143000	usd
CY2023Q1	gram	Non Cash Portion Of Operating Lease Expense NonCashPortionOfOperatingLeaseExpense	219000	usd
CY2024Q1	gram	Finance Lease Interest Expense Noncash FinanceLeaseInterestExpenseNoncash	381000	usd
CY2023Q1	gram	Finance Lease Interest Expense Noncash FinanceLeaseInterestExpenseNoncash	1047000	usd
CY2024Q1	gram	Gain Loss On Extinguishment Of Convertible Debt GainLossOnExtinguishmentOfConvertibleDebt	0	usd
CY2023Q1	gram	Gain Loss On Extinguishment Of Convertible Debt GainLossOnExtinguishmentOfConvertibleDebt	301000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-480000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-104000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	16000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	519000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	168000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	524000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	193000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	56000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-27000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1072000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4125000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-646000	usd
CY2024Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-263000	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	55000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1694000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	618000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7026000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2264000	usd
CY2024Q1	gram	Increase Decrease In Accrued Interest And Accrued Taxes Payable IncreaseDecreaseInAccruedInterestAndAccruedTaxesPayable	5279000	usd
CY2023Q1	gram	Increase Decrease In Accrued Interest And Accrued Taxes Payable IncreaseDecreaseInAccruedInterestAndAccruedTaxesPayable	1895000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4359000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1057000	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	48000	usd
CY2024Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	29000	usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	651000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-680000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3069000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1089000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2500000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	702000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	664000	usd
CY2024Q1	gram	Proceeds From Contributions Net ProceedsFromContributionsNet	0	usd
CY2023Q1	gram	Proceeds From Contributions Net ProceedsFromContributionsNet	97000	usd
CY2024Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	6000	usd
CY2023Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
CY2024Q1	gram	Proceeds From Lease Incentive Payments ProceedsFromLeaseIncentivePayments	499000	usd
CY2023Q1	gram	Proceeds From Lease Incentive Payments ProceedsFromLeaseIncentivePayments	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3278000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	844000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8317000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-278000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22538000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5217000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14221000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4939000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	3630000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	4024000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	405000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	765000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3383000	usd
CY2024Q1	gram	Other Current Assets Reclassed To Property Plant And Equipment OtherCurrentAssetsReclassedToPropertyPlantAndEquipment	0	usd
CY2023Q1	gram	Other Current Assets Reclassed To Property Plant And Equipment OtherCurrentAssetsReclassedToPropertyPlantAndEquipment	2175000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	649000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2024Q1	gram	Reclass Of Equipment Deposits To Property And Equipment ReclassOfEquipmentDepositsToPropertyAndEquipment	0	usd
CY2023Q1	gram	Reclass Of Equipment Deposits To Property And Equipment ReclassOfEquipmentDepositsToPropertyAndEquipment	1044000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1945000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	395000	usd
CY2024Q1	gram	Accrued Interest Added To Principle Of Convertible Notes Payable AccruedInterestAddedToPrincipleOfConvertibleNotesPayable	44000	usd
CY2023Q1	gram	Accrued Interest Added To Principle Of Convertible Notes Payable AccruedInterestAddedToPrincipleOfConvertibleNotesPayable	0	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	NATURE OF OPERATIONS<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gold Flora Corporation, the “Company”, "Gold Flora", and “GFC”, refer to Gold Flora Corporation, a holding company domesticated in the State of Delaware by way of corporate continuance from British Columbia, Canada on July 7, 2023. The Company’s registered office is located at 3165 Red Hill Avenue, Costa Mesa, CA 92626.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gold Flora, LLC is a California limited liability company that was formed on November 15, 2016 and is a vertically integrated single-state operator that, through various subsidiaries, has cultivation, manufacturing, distribution and retail operations in California. While the nature of it's operations is legalized and approved by the State of California, it is considered to be an illegal activity under the Controlled Substances Act of the United States of America (the “CSA”). Accordingly, certain additional risks and uncertainties are present as discussed in the following notes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 7, 2023, the Company consummated a business combination involving TPCO Holding Corp., a publicly traded entity ("TPCO"), Gold Flora, LLC, Stately Capital Corporation, a newly formed British Columbia corporation and Golden Grizzly Bear LLC, which transaction resulted in the combination of TPCO and Gold Flora, LLC, in an all-stock transaction (the “Business Combination”). In connection with the Business Combination, the Company was deemed to be the accounting acquirer and TPCO was the legal acquirer, and for the purpose of facilitating the merger, a new entity, Gold Flora Corporation was formed. Pursuant to the merger, TPCO, Stately Capital Corporation and GFC, amalgamated. The surviving amalgamated company was named GFC and re-domiciled to Delaware, United States and serves as the parent entity for the Gold Flora group of companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:112%">GFC is a single state operator ("SSO") in California and operates as a vertically integrated, licensed, group of cannabis companies. The Company's long-term strategy is to continue to be one of the leading cannabis companies in California. The strategy is to build on the Company's strong integrated market position to pursue profitable organic and selective strategic opportunities with a focus on sustainable cash flow. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company reports its financial accounts and operations in three segments: retail, wholesale, and management. The retail segment consists of the sixteen operating dispensaries in California. The wholesale segment consists of our bulk flower cultivation operations and cannabis products manufacturing which are both sold to third parties. Our management segment represents our corporate office and central costs supporting both the retail and wholesale segments.</span></div>
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	gram	Number Of Dispensaries NumberOfDispensaries	16	dispensary
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-20765000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7248000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-13635000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9322000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4359000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1057000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32153000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15652000	usd
CY2024Q1	gram	Loyalty Program Points Expiration Period LoyaltyProgramPointsExpirationPeriod	P6M
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	0	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	967000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1519000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1882000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12205000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10928000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6326000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5562000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	20050000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	18372000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4534000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1131000	usd
CY2024Q1	us-gaap	Prepaid Rent PrepaidRent	2033000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1808000	usd
CY2024Q1	us-gaap	Supplies Supplies	0	usd
CY2023Q4	us-gaap	Supplies Supplies	515000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2756000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2711000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10290000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6165000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	54497000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	53846000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16615000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14680000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37882000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39166000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	1935000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	861000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53856000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53856000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7755000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46101000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1114000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	772000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15488000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13339000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2518000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2588000	usd
CY2024Q1	gram	Accrued Purchases Current AccruedPurchasesCurrent	6805000	usd
CY2023Q4	gram	Accrued Purchases Current AccruedPurchasesCurrent	2839000	usd
CY2024Q1	gram	Liability To Dissenting Shareholders Current LiabilityToDissentingShareholdersCurrent	3047000	usd
CY2023Q4	gram	Liability To Dissenting Shareholders Current LiabilityToDissentingShareholdersCurrent	3047000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6510000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5529000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	34368000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	27342000	usd
CY2024Q1	gram	Lessee Operating Lease Monthly Payments Maximum Percentage Increase LesseeOperatingLeaseMonthlyPaymentsMaximumPercentageIncrease	0.050
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1001000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	484000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3379000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2574000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	262000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	633000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1536000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	591000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	5654000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	3016000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	702000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	664000	usd
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3021000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1386000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1618000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	486000	usd
CY2024Q1	gram	Proceeds From Lease Incentive Payments ProceedsFromLeaseIncentivePayments	499000	usd
CY2023Q1	gram	Proceeds From Lease Incentive Payments ProceedsFromLeaseIncentivePayments	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	649000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3383000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1945000	usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P25Y4M28D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P23Y3M3D
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y5M15D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M3D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1574
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1563
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1405
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1396
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4901000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	11250000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6574000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	15377000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6632000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	15769000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5636000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	14802000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4338000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	11187000	usd
CY2024Q1	gram	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	17337000	usd
CY2024Q1	gram	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	337419000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	45418000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	405804000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18348000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	317514000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	27070000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	88290000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2776000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3149000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24294000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	85141000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	25198000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	28223000	usd
CY2024Q1	gram	Debt Instrument Unamortized Discount Note Payable DebtInstrumentUnamortizedDiscountNotePayable	73000	usd
CY2023Q4	gram	Debt Instrument Unamortized Discount Note Payable DebtInstrumentUnamortizedDiscountNotePayable	82000	usd
CY2024Q1	gram	Notes Payable Net NotesPayableNet	25125000	usd
CY2023Q4	gram	Notes Payable Net NotesPayableNet	28141000	usd
CY2024Q1	gram	Notes Payable Current Maturities NotesPayableCurrentMaturities	15785000	usd
CY2023Q4	gram	Notes Payable Current Maturities NotesPayableCurrentMaturities	18952000	usd
CY2024Q1	gram	Notes Payable Excluding Current Maturities NotesPayableExcludingCurrentMaturities	9340000	usd
CY2023Q4	gram	Notes Payable Excluding Current Maturities NotesPayableExcludingCurrentMaturities	9189000	usd
CY2024Q1	gram	Convertible Notes Payable Gross ConvertibleNotesPayableGross	21896000	usd
CY2023Q4	gram	Convertible Notes Payable Gross ConvertibleNotesPayableGross	21896000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1182000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1350000	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	20714000	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	20546000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	20714000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	20546000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	287527727	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	287527727	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	287478982	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	287478982	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13948506	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y10M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	18	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.00
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	30000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.11
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	72746	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.11
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13845742	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.17
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y5M19D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13845742	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.17
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y5M19D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3777896	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.33
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y6M29D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	914000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	gram	Related Party Transaction Amounts Of Transaction Incurred Received RelatedPartyTransactionAmountsOfTransactionIncurredReceived	238000	usd
CY2023Q1	gram	Related Party Transaction Amounts Of Transaction Incurred Received RelatedPartyTransactionAmountsOfTransactionIncurredReceived	395000	usd
CY2024Q1	gram	Related Party Transaction Amounts Of Transaction Due To From RelatedPartyTransactionAmountsOfTransactionDueToFrom	1823000	usd
CY2023Q4	gram	Related Party Transaction Amounts Of Transaction Due To From RelatedPartyTransactionAmountsOfTransactionDueToFrom	1793000	usd
CY2024Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12717000	usd
CY2023Q1	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-8576000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	987000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	765000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.078
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.089
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14221000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14221000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3073000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	228000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2845000	usd
CY2024Q1	gram	Deposits And Other Long Term Assets DepositsAndOtherLongTermAssets	4236000	usd
CY2024Q1	gram	Deposits And Other Long Term Assets DepositsAndOtherLongTermAssets	4236000	usd
CY2024Q1	gram	Notes Receivable NotesReceivable	696000	usd
CY2024Q1	gram	Notes Receivable NotesReceivable	696000	usd
CY2024Q1	gram	Assets Credit Risk Gross AssetsCreditRiskGross	22226000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	228000	usd
CY2024Q1	gram	Assets Credit Risk Net AssetsCreditRiskNet	21998000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22538000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22538000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2009000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	236000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1773000	usd
CY2023Q4	gram	Deposits And Other Long Term Assets DepositsAndOtherLongTermAssets	3973000	usd
CY2023Q4	gram	Deposits And Other Long Term Assets DepositsAndOtherLongTermAssets	3973000	usd
CY2023Q4	gram	Notes Receivable NotesReceivable	667000	usd
CY2023Q4	gram	Notes Receivable NotesReceivable	667000	usd
CY2023Q4	gram	Assets Credit Risk Gross AssetsCreditRiskGross	29187000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	236000	usd
CY2023Q4	gram	Assets Credit Risk Net AssetsCreditRiskNet	28951000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q1	us-gaap	Assets Assets	220610000	usd
CY2023Q4	us-gaap	Assets Assets	226366000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32153000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15652000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4050000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2117000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	4328000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	4705000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	987000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	765000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6188000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2282000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-27000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	855000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	269000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7036000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4078000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	193000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1536000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	591000	usd
CY2024Q1	gram	Depreciation And Finance Lease Right Of Use Asset Amortization DepreciationAndFinanceLeaseRightOfUseAssetAmortization	2044000	usd
CY2023Q1	gram	Depreciation And Finance Lease Right Of Use Asset Amortization DepreciationAndFinanceLeaseRightOfUseAssetAmortization	912000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1114000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	772000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18966000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8933000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-13635000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9322000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	395000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13635000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9717000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	287515421	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94346683	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	287515421	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94346683	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	73653903	shares
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001876945-24-000044-index-headers.html	Edgar Link	pending
0001876945-24-000044-index.html	Edgar Link	pending
0001876945-24-000044.txt	Edgar Link	pending
0001876945-24-000044-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gram-20240331.htm	Edgar Link	pending
gram-20240331.xsd	Edgar Link	pending
gram-20240331x10qexx311.htm	Edgar Link	pending
gram-20240331x10qexx312.htm	Edgar Link	pending
gram-20240331x10qexx321.htm	Edgar Link	pending
gram-20240331x10qexx322.htm	Edgar Link	pending
gram-20240331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
gram-20240331_cal.xml	Edgar Link	unprocessable
gram-20240331_def.xml	Edgar Link	unprocessable
gram-20240331_lab.xml	Edgar Link	unprocessable
gram-20240331_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gram-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRAM
Gold Flora Corp. Stock $gram

2024 Q2 Form 10-Q Financial Statement

#000187694524000044 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRAM Gold Flora Corp. Stock $gram

2024 Q2 Form 10-Q Financial Statement

#000187694524000044 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRAM
Gold Flora Corp. Stock $gram